Video

Educating Fetal and Maternal Patients on Cardiovascular Risks

Author(s):

Montefiore experts discuss the emphasis on education at their MFM-Cardiology care program.

Launching a cross-specialty collaborative care center inherently requires educational resources; merging 2 generally disassociated fields is introducing new language and practices to different patients, different care providers, and different program managers.

Launching a collaborative care center that merges fetal-maternal medicine and cardiovascular prevention, though, requires a refined understanding of “education.”

In the second segment of an interview with HCPLive for World Heart Day, obstetrician-gynecologist Diana Wolfe, MD, MPH, and cardiologist Anna Bortnick, MD, PhD, co-founders of the Maternal and Fetal Medicine (MFM)-Cardiology Joint Program at Montefiore, discussed their strategies for educating MFM patients on heart disease—and heart disease patients on maternal-fetal health.

Unsurprisingly, they’ve also become well-versed in educating their peers on such topics, as well as similar program organizers: their program has offered patient literature, CME courses, and formal guidances all the same on these topics.

“We have dedicated a lot of time to each patient encounter, so we do make it very open-ended so there’s time for the patient to ask,” Wolfe said, adding that patient-centric subjects can often delve into reproductive life planning, contraception, and birth spacing.

Bortnick, who’s often tasked with introducing various cardiovascular risks and treatment plans to MFM patients and prescribers alike, said their strategy is to create an environment where anything can be asked.

“We’ll try to figure out what the patient knows about their condition, and what kind of questions we can answer," she said. “Because oftentimes they have preconceived ideas—maybe things they’ve heard from family and friends—and they may not have all the information they want.”

Related Videos
Highlighting Recent Therapies for Dermatologists, with James Del Rosso, DO
Rahul N. Khurana, MD: Phase 1 Results on Vamikibart for Uveitic Macular Edema | Image Credit: Northern California Retina Vitreous Associates
Sunir J. Garg, MD: | Image Credit: Wills Eye Hospital
James Del Rosso, DO: Discussing What’s New in the Medicine Chest for Dermatologists
What to Look Forward To at the Fall Clinical Dermatology Conference, with Raj Chovatiya, MD, PhD
Christine N. Kay, MD: Interim Data on ATSN-201 Shows Promise for XLRS | Image Credit: Vitreo Retinal Associates
Arshad Khanani, MD: First Results from Fellow Eye Dosing of RGX-314 in nAMD | Image Credit: Sierra Eye Associates
Jonathan Barratt, MD | Credit: IgA Nephropathy Foundation
How Artificial Intelligence is Being Used in Lung Imaging, with Rachel Eddy, PhD
© 2024 MJH Life Sciences

All rights reserved.